Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Nedoszytko, Bogusław [VerfasserIn]   i
 Arock, Michel [VerfasserIn]   i
 Lyons, Jonathan J. [VerfasserIn]   i
 Bachelot, Guillaume [VerfasserIn]   i
 Schwartz, Lawrence B. [VerfasserIn]   i
 Reiter, Andreas [VerfasserIn]   i
 Jawhar, Mohamad [VerfasserIn]   i
 Schwaab, Juliana [VerfasserIn]   i
 Lange, Magdalena [VerfasserIn]   i
 Greiner, Georg [VerfasserIn]   i
 Hoermann, Gregor [VerfasserIn]   i
 Niedoszytko, Marek [VerfasserIn]   i
 Metcalfe, Dean D. [VerfasserIn]   i
 Valent, Peter [VerfasserIn]   i
Titel:Clinical impact of inherited and acquired genetic variants in mastocytosis
Verf.angabe:Boguslaw Nedoszytko, Michel Arock, Jonathan J. Lyons, Guillaume Bachelot, Lawrence B. Schwartz, Andreas Reiter, Mohamad Jawhar, Juliana Schwaab, Magdalena Lange, Georg Greiner, Gregor Hoermann, Marek Niedoszytko, Dean D. Metcalfe and Peter Valent
E-Jahr:2021
Jahr:2 January 2021
Umfang:18 S.
Teil:volume:22
 year:2021
 number:1
 elocationid:411
 pages:1-18
 extent:18
Fussnoten:Gesehen am 10.05.2021
Titel Quelle:Enthalten in: International journal of molecular sciences
Ort Quelle:Basel : Molecular Diversity Preservation International, 2000
Jahr Quelle:2021
Band/Heft Quelle:22(2021), 1, Artikel-ID 411, Seite 1-18
ISSN Quelle:1422-0067
 1661-6596
Abstract:Mastocytosis is a rare and complex disease characterized by expansion of clonal mast cells (MC) in skin and/or various internal organ systems. Involvement of internal organs leads to the diagnosis of systemic mastocyt!1446321282!osis (SM). The WHO classification divides SM into indolent SM, smoldering SM and advanced SM variants, including SM with an associated hematologic neoplasm, aggressive SM, and MC leukemia. Historically, genetic analysis of individuals with pure cutaneous mastocytosis (CM) and SM have focused primarily on cohort studies of inherited single nucleotide variants and acquired pathogenic variants. The most prevalent pathogenic variant (mutation) in patients with SM is KIT p.D816V, which is detectable in most adult patients. Other somatic mutations have also been identified—especially in advanced SM—in TET2, SRSF2, ASXL1, RUNX1, CBL and JAK2, and shown to impact clinical and cellular phenotypes. Although only small patient cohorts have been analyzed, disease associations have also been identified in several germline variants within genes encoding certain cytokines or their receptors (IL13, IL6, IL6R, IL31, IL4R) and toll-like receptors. More recently, an increased prevalence of hereditary alpha-tryptasemia (HαT) caused by increased TPSAB1 copy number encoding alpha-tryptase has been described in patients with SM. Whereas HαT is found in 3-6% of general Western populations, it is identified in up to 17% of patients with SM. In the current manuscript we review the prevalence, functional role and clinical impact of various germline and somatic genetic variants in patients with mastocytosis.
DOI:doi:10.3390/ijms22010411
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext ; Verlag: https://doi.org/10.3390/ijms22010411
 Volltext: https://www.mdpi.com/1422-0067/22/1/411
 DOI: https://doi.org/10.3390/ijms22010411
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:<i>KIT</i> variants
 gene polymorphisms
 hereditary alpha-tryptasemia
 mast cell activation syndrome
 mast cells
 prognostication
K10plus-PPN:1757549781
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68735754   QR-Code

zum Seitenanfang